US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regeneron Pharmaceuticals

573.45

-37.1900-6.09%

Post-market: 555.17-18.2830-3.19%19:58 EDT

Volume:1.55M

Turnover:908.00M

Market Cap:62.69B

PE:14.96

High:612.99

Open:610.65

Low:572.00

Close:610.64

Loading ...

Overview Company News Filings

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-03-10

AMGN's Eczema Drug Meets Goal in Two Late-Stage Studies

Regeneron, Sanofi presents results from ADEPT Phase 2/3 trial on Dupixent

Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

BUZZ- Some defensives outperform, even as indexes switch to gains

The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals

Regeneron’s treatment of lipodystrophy granted FDA orphan designation

Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More

Why Is Regeneron (REGN) Down 4.1% Since Last Earnings Report?

Regeneron Canada: Completed Negotiations With Pan-Canadian Pharmaceutical Alliance for Reimbursement of Libtayo

THOMSON REUTERS

TD Cowen Sticks to Their Buy Rating for Regeneron (REGN)

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Is Regeneron Pharmaceuticals, Inc. (REGN) the Worst Performing Large Cap Stock to Buy According to Analysts?

Regeneron Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Regeneron Gets Positive CHMP Opinion for Multiple Myeloma Drug

Apogee Therapeutics' Investigational Atopic Dermatitis Potential Shows Strong Tolerability, Extended Half-Life in Early Trial

Regeneron Says Linvoseltamab Recommended for EU Approval to Treat Multiple Myeloma

MT Newswires Live

Regeneron Gets CHMP Backing of Linvoseltamab in Multiple Myeloma

Linvoseltamab Recommended for EU Approval by the Chmp to Treat Relapsed/Refractory Multiple Myeloma

THOMSON REUTERS

Regeneron Pharmaceuticals Inc - European Commission Final Decision Expected in Coming Months

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/REGN/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"REGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REGN\",,,,,undefined,":{"symbol":"REGN","market":"US","secType":"STK","nameCN":"Regeneron Pharmaceuticals","latestPrice":573.45,"timestamp":1743796800000,"preClose":610.64,"halted":0,"volume":1547948,"hourTrading":{"tag":"盘后","latestPrice":555.167,"preClose":573.45,"latestTime":"19:58 EDT","volume":50046,"amount":28695435.1948,"timestamp":1743811137428},"delay":0,"floatShares":105000000,"shares":109324682,"eps":38.34,"marketStatus":"Market Closed","change":-37.19,"latestTime":"04-04 16:00:00 EDT","open":610.65,"high":612.99,"low":572,"amount":908003851.554,"amplitude":0.067126,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":38.34,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1744012800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":610.64,"preHourTrading":{"tag":"盘前","latestPrice":614.85,"preClose":610.64,"latestTime":"09:29 EDT","volume":12474,"amount":7609829.8122,"timestamp":1743773351939},"postHourTrading":{"tag":"盘后","latestPrice":555.167,"preClose":573.45,"latestTime":"19:58 EDT","volume":50046,"amount":28695435.1948,"timestamp":1743811137428},"volumeRatio":1.5854277986514484,"impliedVol":0.5353,"impliedVolPercentile":0.996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REGN\",,,,,undefined,":{"symbol":"REGN","floatShares":105000000,"roa":"7.31%","roe":"15.95%","lyrEps":40.895273,"volumeRatio":1.5854277986514484,"shares":109324682,"dividePrice":3.52,"high":612.99,"amplitude":0.067126,"preClose":610.64,"low":572,"week52Low":572,"pbRate":"2.14","psRate":"4.41","week52High":1211.2,"institutionHeld":0.8855,"latestPrice":573.45,"eps":38.34,"divideRate":0.006138,"volume":1547948,"delay":0,"ttmEps":38.34,"open":610.65,"prevYearClose":712.33,"prevWeekClose":637.36,"prevMonthClose":634.23,"prevQuarterClose":634.23,"fiveDayClose":637.36,"twentyDayClose":707.51,"sixtyDayClose":730.3,"earningDate":1745856000000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"REGN\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518276250","title":"BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-03-10","url":"https://stock-news.laohu8.com/highlight/detail?id=2518276250","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518276250?lang=en_us&edition=fundamental","pubTime":"2025-03-10 23:01","pubTimestamp":1741618864,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-03-10Nasdaq 100 .NDXTop PerformersPercent ChangePaccar Inc PCAR.OQ+4.7%Regeneron Pharmaceuticals Inc REGN.OQ+4.7%CoStar G","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL8N3PT1D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","LU2125909593.SGD","LU0738911758.USD","LU1548497426.USD","LU1992135472.HKD","LU2326559502.SGD","LU0553294199.USD","LU0640476718.USD","BK4548","LU1861220033.SGD","PCAR","STRK","BIIB","BK4149","MDLZ","LU2357305700.SGD","REGN","IE00B19Z9P08.USD","BK4592","TSYW.SI","LU0823414478.USD","TEAM","LU1145028129.USD","LU2264538146.SGD","CSGP","IE00BJLML261.HKD","LU0323591593.USD","BK4588","LU2756315664.SGD","LU0053666078.USD","LU1267930730.SGD","BK4527","LU1778281490.HKD","LU0882574055.USD","LU2272731600.USD","IE00B19Z9Z06.USD","LU0390134368.USD","BK4212","LU2125909916.SGD","LU2362540622.SGD","LU0823416689.USD","BK4596","LU2756315318.SGD","IE0034235303.USD","LU1861215975.USD"],"gpt_icon":1},{"id":"2518271380","title":"AMGN's Eczema Drug Meets Goal in Two Late-Stage Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2518271380","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518271380?lang=en_us&edition=fundamental","pubTime":"2025-03-10 21:27","pubTimestamp":1741613220,"startTime":"0","endTime":"0","summary":"Amgen AMGN announced positive results from two clinical studies, IGNITE and SHUTTLE, which are part of the phase III ROCKET program that is evaluating the investigational anti-OX40 therapy rocatinlimab for atopic dermatitis  indication in adults.While the IGNITE study evaluated rocatinlimab as monotherapy for 24 weeks, the SHUTTLE study evaluated the drug in combination with topical corticosteroids  and/or topical calcineurin inhibitors  over the same timeframe. Both studies met their primary and key secondary endpoints.The IGNITE study evaluated two dose levels of the drug — high and low. Treatment with both these dose levels met the study’s co-primary endpoints of EASI-75  and validated Investigator's Global Assessment for Atopic Dermatitis .In the high-dose group, 42.3% of patients achieved EASI-75 , with a placebo-adjusted difference of 29.5%. In the lower-dose group, 36.3% of patients reached EASI-75, showing a placebo-adjusted improvement of 23.4%.For the vIGA-AD endpoint, 26.1% ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amgns-eczema-drug-meets-goal-132700356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4599","LU2112291526.USD","LU2023250504.SGD","LU0868494617.USD","BK4581","LU0053666078.USD","IE0009355771.USD","LU0320765992.SGD","BK4205","LU1057294990.SGD","LU0882574055.USD","TCS","BK4533","AMGN","LU1571399168.USD","BK4585","LU1917777945.USD","IE00BFXG1179.USD","LU2242646821.SGD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU2106854487.HKD","BK4200","LU0109394709.USD","LU2362541513.USD","BK4534","BK4566","LU2362541273.HKD","LU1974910355.USD","LU1061106388.HKD","LU1023059063.AUD","LU0114720955.EUR","BK4007","IE0002141913.USD","SSI","IE00BJT1NW94.SGD","LU2089984988.USD","LU0289739699.SGD","REGN","IE00BJJMRZ35.SGD","BK4233","LU2242652126.USD","SG9999001440.SGD","TCI","IE00B2B36J28.USD","LU2362540622.SGD","LU0889565916.HKD","LU0058720904.USD","SNY"],"gpt_icon":0},{"id":"2518231175","title":"Regeneron, Sanofi presents results from ADEPT Phase 2/3 trial on Dupixent","url":"https://stock-news.laohu8.com/highlight/detail?id=2518231175","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518231175?lang=en_us&edition=fundamental","pubTime":"2025-03-10 06:40","pubTimestamp":1741560007,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) presented positive results from the pivotal ADEPT Phase 2/3 trial evaluating the investigational ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regeneron-sanofi-presents-results-from-adept-phase-2-3-trial-on-dupixent?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regeneron-sanofi-presents-results-from-adept-phase-2-3-trial-on-dupixent?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237438978.USD","LU2362541513.USD","LU0882574055.USD","LU1917777945.USD","LU0320765992.SGD","BK4139","BK4007","LU2362541273.HKD","LU0823416689.USD","LU0289739699.SGD","LU0114720955.EUR","LU0053666078.USD","LU2362540622.SGD","SNYNF","LU2023250504.SGD","LU2468319806.SGD","IE00BFXG1179.USD","LU2089984988.USD","LU0109394709.USD","BK4585","LU0058720904.USD","LU0889565916.HKD","SNY","REGN","LU1974910355.USD","LU2106854487.HKD","BK4588"],"gpt_icon":0},{"id":"2517446938","title":"Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2517446938","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517446938?lang=en_us&edition=fundamental","pubTime":"2025-03-08 05:41","pubTimestamp":1741383660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  rose 1.30% to $707.51 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.55% to 5,770.20 and the Dow Jones Industrial Average  rising 0.52% to 42,801.72.This was the stock's third consecutive day of gains.Regeneron Pharmaceuticals Inc. closed 41.59% short of its 52-week high of $1,211.20, which the company achieved on August 27th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Amgen Inc.  rose 2.22% to $324.86, Moderna Inc.  rose 3.82% to $35.61, and Gilead Sciences Inc.  rose 1.18% to $117.41.Data source: Dow Jones Market Data, FactSet. Data compiled March 7, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"gpt_icon":0},{"id":"2517457773","title":"BUZZ- Some defensives outperform, even as indexes switch to gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2517457773","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517457773?lang=en_us&edition=fundamental","pubTime":"2025-03-08 03:59","pubTimestamp":1741377563,"startTime":"0","endTime":"0","summary":"BUZZ- Some defensives outperform, even as indexes switch to gains ** Some traditionally defensive stocks were outperforming on Friday afternoon, even as the broader market mood looked brighter, as inv","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nL2N3PQ0Y2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DG","DVA","REGN","CAG","WBA","SJM","CPB","GIS","BIIB","KHC"],"gpt_icon":1},{"id":"2517106220","title":"The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2517106220","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517106220?lang=en_us&edition=fundamental","pubTime":"2025-03-07 15:59","pubTimestamp":1741334340,"startTime":"0","endTime":"0","summary":"Chicago, IL – March 7, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Jazz Pharmaceuticals JAZZ, Chimerix CMRX, Moderna MRNA, GSK plc GSK and Regeneron Pharmaceuticals, Inc. REGN.Mergers and acquisitions grabbed the spotlight in the biotech sector this week after Jazz Pharmaceuticals announced an agreement to acquire Chimerix. Meanwhile, other pipeline and regulatory updates were in focus.Shares of clinical-stage biotech Chimerix skyrocketed following an acquisition agreement from Jazz Pharmaceuticals for $8.55 per share in cash, aggregating to nearly $935 million.The offer price reflects an approximately 72% premium based on CMRX’ closing price on Tuesday.The BLA is seeking approval of the candidate as an add-on maintenance treatment of asthma in adult and pediatric patients aged 12 years a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-analyst-blog-jazz-pharmaceuticals-075900590.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0321505868.SGD","LU2468319806.SGD","IE00B19Z3581.USD","LU0306806265.USD","BK4532","LU0456855351.SGD","LU0225771236.USD","LU0320765992.SGD","LU2362541513.USD","LU0321505439.SGD","LU0058720904.USD","IE00B19Z3B42.SGD","LU0114720955.EUR","REGN","SG9999001176.USD","LU0122379950.USD","BK4585","LU0985481810.HKD","IE00BN0W2W23.USD","LU0889565916.HKD","LU1974910355.USD","LU0109394709.USD","LU1917777945.USD","JAZZ","LU1066051498.USD","LU0306807586.USD","GSK","BK4007","GSK.UK","SG9999013999.USD","SGXZ57979304.SGD","LU2362541273.HKD","BK4550","SG9999003800.SGD","MRNA","BK4568","IE00BLSP4452.SGD","LU2089984988.USD","BK4551","CMRX","LU2023250504.SGD","BK4533","LU0234572021.USD","LU0868494617.USD","SG9999011175.SGD","LU0882574055.USD","LU0170899867.USD","BK4534","IE00BBT3K403.USD"],"gpt_icon":1},{"id":"2517112824","title":"Regeneron’s treatment of lipodystrophy granted FDA orphan designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2517112824","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517112824?lang=en_us&edition=fundamental","pubTime":"2025-03-07 07:01","pubTimestamp":1741302064,"startTime":"0","endTime":"0","summary":"Regeneron’s (REGN) treatment of lipodystrophy, mibavademab, was granted FDA orphan designation, according to a post on the agency’s website. Publis...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regenerons-treatment-of-lipodystrophy-granted-fda-orphan-designation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regenerons-treatment-of-lipodystrophy-granted-fda-orphan-designation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1917777945.USD","LU0114720955.EUR","LU0289739699.SGD","LU2106854487.HKD","REGN","LU2237438978.USD","LU2468319806.SGD","LU2089984988.USD","LU2362541273.HKD","LU0889565916.HKD","BK4588","LU0320765992.SGD","BK4585","LU1974910355.USD","LU0053666078.USD","LU2023250504.SGD","LU0109394709.USD","LU0058720904.USD","LU0882574055.USD","LU2362540622.SGD","LU0823416689.USD","BK4139","LU2362541513.USD"],"gpt_icon":0},{"id":"2517113483","title":"Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More","url":"https://stock-news.laohu8.com/highlight/detail?id=2517113483","media":"Zacks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517113483?lang=en_us&edition=fundamental","pubTime":"2025-03-07 04:00","pubTimestamp":1741291200,"startTime":"0","endTime":"0","summary":"Mergers and acquisitions grabbed the spotlight in the biotech sector this week after Jazz Pharmaceuticals JAZZ announced an agreement to acquire Chimerix CMRX. Meanwhile, other pipeline and regulatory updates were in focus.Shares of clinical-stage biotech Chimerix skyrocketed following an acquisition agreement from Jazz Pharmaceuticals for $8.55 per share in cash, aggregating to nearly $935 million.The offer price reflects an approximately 72% premium based on CMRX’ closing price on Tuesday.The acquisition will add CMRX’s lead pipeline drug, dordaviprone, to Jazz’s pipeline. This drug is currently under review by the FDA under the accelerated approval pathway as a potential treatment for adult and pediatric patients with recurrent H3 K27M-mutant diffuse glioma. A final decision is expected by Aug. 18, 2025.The BLA is based on data from positive SWIFT and ANCHOR trials. SWIFT-1 and -2 showed depemokimab reduced exacerbation and hospitalization rates as an add-on therapy for patients wit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-stocks-roundup-cmrx-jazz-200000996.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1829250122.USD","SG9999013999.USD","LU1883839398.USD","SGXZ57979304.SGD","LU1066051498.USD","CMRX","LU0321505868.SGD","LU0823416689.USD","BK4533","IE00BN0W2T93.GBP","LU0456855351.SGD","LU1066053197.SGD","LU1057294990.SGD","LU0868494617.USD","LU2237438978.USD","LU0985481810.HKD","JAZZ","BK4501","LU1023059063.AUD","IE00BLSP4239.USD","MRNA","BK4139","BK4583","BK4568","LU2362541273.HKD","REGN","LU1974910355.USD","BK4532","LU1917777945.USD","SG9999001176.USD","BK4588","GSK","LU2362541513.USD","SG9999001176.SGD","LU0053666078.USD","LU0122379950.USD","IE00B19Z3581.USD","LU0114720955.EUR","BK4592","LU0289739699.SGD","BK4581","IE000M9KFDE8.USD","GSK.UK","LU0225284248.USD","LU1894683264.USD","LU0306806265.USD","IE00B19Z3B42.SGD","IE00BN0W2V16.EUR","LU2023250504.SGD"],"gpt_icon":1},{"id":"2517199164","title":"Why Is Regeneron (REGN) Down 4.1% Since Last Earnings Report?","url":"https://stock-news.laohu8.com/highlight/detail?id=2517199164","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517199164?lang=en_us&edition=fundamental","pubTime":"2025-03-07 00:31","pubTimestamp":1741278672,"startTime":"0","endTime":"0","summary":"It has been about a month since the last earnings report for Regeneron . Shares have lost about 4.1% in that time frame, underperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is Regeneron due for a breakout?Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.Regeneron Beats on Q4 Earnings, Initiates Quarterly Dividend. Total revenues increased 10% year over year to $3.79 billion, fueled by increased collaboration revenues from Sanofi for Dupixent, higher Eylea HD and Libtayo sales. Revenues marginally beat the Zacks Consensus Estimate of $3.78 billion.Eylea’s sales in the United States declined 11% year over year to $1.2 billion, primarily due to increased competition.Please note that Regeneron co-developed Eylea with the HealthCare unit of Bayer AG. Regeneron records net product sales of Eylea ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-regeneron-regn-down-4-163112173.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["REGN","SNY"],"gpt_icon":0},{"id":"2517526061","title":"Regeneron Canada: Completed Negotiations With Pan-Canadian Pharmaceutical Alliance for Reimbursement of Libtayo","url":"https://stock-news.laohu8.com/highlight/detail?id=2517526061","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517526061?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:14","pubTimestamp":1741266866,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nFWN3PP0GG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2362540622.SGD","LU2362541513.USD","LU0823416689.USD","LU0320765992.SGD","LU2106854487.HKD","LU1974910355.USD","BK4585","LU2089984988.USD","LU0882574055.USD","BK4139","LU0053666078.USD","LU0109394709.USD","LU1917777945.USD","LU2237438978.USD","BK4588","LU2468319806.SGD","REGN","LU0289739699.SGD","LU2362541273.HKD","LU2023250504.SGD","LU0114720955.EUR","LU0058720904.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2517154491","title":"TD Cowen Sticks to Their Buy Rating for Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517154491","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517154491?lang=en_us&edition=fundamental","pubTime":"2025-03-06 20:57","pubTimestamp":1741265860,"startTime":"0","endTime":"0","summary":"In a report released today, Tyler Van Buren from TD Cowen maintained a Buy rating on Regeneron (REGN – Research Report), with a price target of $97...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/td-cowen-sticks-to-their-buy-rating-for-regeneron-regn-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/td-cowen-sticks-to-their-buy-rating-for-regeneron-regn-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REGN","COWN","TD"],"gpt_icon":0},{"id":"2517924750","title":"Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2517924750","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517924750?lang=en_us&edition=fundamental","pubTime":"2025-03-06 05:43","pubTimestamp":1741210980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  rose 1.73% to $687.15 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 1.12% to 5,842.63 and the Dow Jones Industrial Average  rising 1.14% to 43,006.59.The stock's rise snapped a five-day losing streak.Regeneron Pharmaceuticals Inc. closed 43.27% short of its 52-week high of $1,211.20, which the company reached on August 27th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc.  rose 1.40% to $316.57, Moderna Inc.  rose 15.94% to $35.21, and Gilead Sciences Inc.  rose 0.61% to $115.44.Trading volume  remained 86,208 below its 50-day average volume of 902,484.Data source: Dow Jones Market Data, FactSet. Data compiled March 5, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"gpt_icon":0},{"id":"2516621183","title":"Is Regeneron Pharmaceuticals, Inc. (REGN) the Worst Performing Large Cap Stock to Buy According to Analysts?","url":"https://stock-news.laohu8.com/highlight/detail?id=2516621183","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516621183?lang=en_us&edition=fundamental","pubTime":"2025-03-04 18:27","pubTimestamp":1741084029,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Worst Performing Large Cap Stocks to Buy According to Analysts. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc.  stands against other worst performing large cap stocks to buy according to analysts.How Did The Market Perform in Q4 2024?On January 21, Russell Investment released its Equity Factor report highlighting key trends and performances in global equity markets during the fourth quarter of 2024. The period was marked by significant events, including the conclusion of the US presidential election, which led to heightened expectations of economic growth, deregulation, and lower taxes. These factors contributed to a robust return of 2.7% for the Russell 1000 Index, which tracks the performance of large-cap US companies by market capitalization.READ ALSO:10 Best Performing Large Cap Stocks to Buy According to Analystsand10 Best Small-Cap Growth Stocks to Buy Now.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/regeneron-pharmaceuticals-inc-regn-worst-102709826.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2023250504.SGD","LU2362541273.HKD","USAW.SI","NQmain","LU0058720904.USD","MNQmain","LU0823416689.USD","LU2089984988.USD","USJW.SI","BK4585","LU2237438978.USD","PSQ","LU0882574055.USD","QID","ABR","LU0889565916.HKD","LU2362540622.SGD","LU0109394709.USD","SQQQ","REGN","LU0114720955.EUR","NVIW.SI","BK4139","PTA","LU1917777945.USD","LU1974910355.USD","LU2468319806.SGD","QLD","BK4588","LU2362541513.USD","TSYW.SI",".IXIC","LU0289739699.SGD","LU2106854487.HKD","BK4110","LU0320765992.SGD","LU0053666078.USD","TQQQ"],"gpt_icon":1},{"id":"2516669708","title":"Regeneron Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2516669708","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516669708?lang=en_us&edition=fundamental","pubTime":"2025-03-04 05:42","pubTimestamp":1741038120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  shed 1.99% to $684.87 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 1.76% to 5,849.72 and Dow Jones Industrial Average  falling 1.48% to 43,191.24.This was the stock's fourth consecutive day of losses.Regeneron Pharmaceuticals Inc. closed 43.46% below its 52-week high of $1,211.20, which the company achieved on August 27th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Amgen Inc.  rose 0.88% to $310.78, Moderna Inc.  fell 2.23% to $30.27, and Gilead Sciences Inc.  rose 1.47% to $115.99.Trading volume  remained 194,037 below its 50-day average volume of 902,340.Data source: Dow Jones Market Data, FactSet. Data compiled March 3, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is publishe","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"gpt_icon":0},{"id":"2516944666","title":"Regeneron Gets Positive CHMP Opinion for Multiple Myeloma Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2516944666","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516944666?lang=en_us&edition=fundamental","pubTime":"2025-03-04 04:00","pubTimestamp":1741032000,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals, Inc. REGN obtained positive opinion for its pipeline candidate linvoseltamab from the European Medicines Agency’s  Committee for Medicinal Products for Human Use .The CHMP recommended conditional marketing authorization of linvoseltamab to treat adults with relapsed and refractory (R/R) multiple myeloma . The recommendation is specific to those who have received at least three prior therapies, including a proteasome inhibitor, an immunomodulatory agent and an anti-CD38 monoclonal antibody, and have demonstrated disease progression on the last therapy.A final decision is expected in the coming months.Regeneron’s shares have lost 30.5% in the past year compared with the medical-biomedical genetics industry’s decline of 6.7%.Regeneron Pharmaceuticals Stock Price, Consensus and EPS Surprise. Regeneron Pharmaceuticals, Inc. price-consensus-eps-surprise-chart | Regeneron Pharmaceuticals, Inc. Quote. REGN’s oncology franchise got a boost with the European Commission","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/regeneron-gets-positive-chmp-opinion-200000419.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2237438978.USD","03165","IE00B7SZLL34.SGD","LU0882574055.USD","BK4087","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","LU0320765992.SGD","BK4139","LU1917777945.USD","LU2362541513.USD","BK4007","IE00BKVL7J92.USD","BK4532","LU0823416689.USD","BK4566","GILD","LU0289739699.SGD","LU1839511570.USD","IE00B3T34201.USD","IE00BSNM7G36.USD","BK4550","BK4568","LU0114720955.EUR","LU0053666078.USD","LU2362540622.SGD","LU1585245621.USD","BK4094","LU0234570918.USD","LU1430594728.SGD","LU2023250504.SGD","LU2468319806.SGD","FL","LU2089984988.USD","IE00B19Z3581.USD","BK4585","LU0058720904.USD","LU0109394709.USD","LU0889565916.HKD","LU2087621335.USD","REGN","LU1974910355.USD","LU1066053197.SGD","CHMP","BMRN","IE0002270589.USD","LU1066051498.USD","BK4583","RHHBY","LU2106854487.HKD"],"gpt_icon":0},{"id":"2516752656","title":"Apogee Therapeutics' Investigational Atopic Dermatitis Potential Shows Strong Tolerability, Extended Half-Life in Early Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2516752656","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516752656?lang=en_us&edition=fundamental","pubTime":"2025-03-04 01:16","pubTimestamp":1741022203,"startTime":"0","endTime":"0","summary":"On Monday, Apogee Therapeutics, Inc.  released interim Phase 1 results from its first-in-human trial of APG990.APG990 interim Phase 1 pharmacokinetic  data showed a half-life of approximately 60 days across doses tested.Key data from the 40-healthy subject trial showed:. APG990 demonstrated a potential best-in-class PK profile, including a half-life of approximately 60 days, supporting the potential for every three- and six-month maintenance dosing. The PK profile supports the potential for a single 2 mL co-formulated injection of APG279  administered every three and six months.APG990 was well tolerated across all five cohorts, with doses up to 1,200mg. The most common  treatment-emergent adverse events  were headache.53% of participants observed at least one TEAE.In addition, preclinical studies of the combination of APG777 and APG990 showed potential for enhanced pharmacologic responses relative to individual agents and exhibited no safety findings at any dose level, including the hi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/apogee-therapeutics-investigational-atopic-dermatitis-171643556.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1974910355.USD","APGE","LU0289739699.SGD","LU0823416689.USD","BK4181","LU0320765992.SGD","LU2089984988.USD","BK4588","USAW.SI","QID","NVIW.SI","NQmain","QLD","LU2362541513.USD","REGN","LU2237438978.USD","BK4218","LU0889565916.HKD","LU1917777945.USD","LU2468319806.SGD","TSYW.SI","BK4007","LU2362541273.HKD","LU0053666078.USD","IE00BFXG1179.USD","PK",".IXIC","LU2106854487.HKD","BK4585","SNY","MNQmain","LU2023250504.SGD","SQQQ","PSQ","LU0114720955.EUR","USJW.SI","TQQQ","LU2362540622.SGD","BK4139","LU0882574055.USD","LU0058720904.USD","LU0109394709.USD"],"gpt_icon":1},{"id":"2514265893","title":"Regeneron Says Linvoseltamab Recommended for EU Approval to Treat Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2514265893","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514265893?lang=en_us&edition=fundamental","pubTime":"2025-02-28 20:40","pubTimestamp":1740746435,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals  said Friday that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended a conditional marketing authorization for linvoseltamab to treat adults with relapsed and refractory multiple myeloma.The company said the recommendation specifically covers patients who have received at least three prior therapies.The committee's positive opinion was based on data from a phase 1/2 trial investigating linvoseltamab in 282 patients, Regeneron said.The European Commission is expected to issue a final decision in the coming months, the company said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4156","LU0823416689.USD","LU2362541513.USD","LU2237438978.USD","LU2468319806.SGD","BK4588","LU0109394709.USD","LU0289739699.SGD","REGN","LU0058720904.USD","LU0882574055.USD","LU0320765992.SGD","LU2023250504.SGD","LU2089984988.USD","BK4585","LU0889565916.HKD","BK4139","LU2106854487.HKD","LU1974910355.USD","LU0114720955.EUR","LU2362541273.HKD","LU0053666078.USD","LU2362540622.SGD","LU1917777945.USD"],"gpt_icon":0},{"id":"2514326082","title":"Regeneron Gets CHMP Backing of Linvoseltamab in Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2514326082","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514326082?lang=en_us&edition=fundamental","pubTime":"2025-02-28 20:34","pubTimestamp":1740746040,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended conditional marketing approval of linvoseltamab for certain adults with the blood cancer multiple myeloma.Regeneron on Friday said the recommendation covers adults with adults with relapsed and refractory multiple myeloma who have received at least three prior therapies, including a proteasome inhibitor, an immunomodulatory agent and an anti-CD38 monoclonal antibody, and have shown disease progression on the last therapy.The Tarrytown, N.Y., biotechnology company said the European Commission, which generally follows the CHMP's advice, is expected to announce a final decision in the coming months.The U.S. Food and Drug Administration earlier this month accepted Regeneron's resubmitted application seeking approval of linvoseltamab and set a target action date of July 10 for a decision.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4087","LU0882574055.USD","LU0823416689.USD","LU1917777945.USD","BK4588","LU0053666078.USD","LU0320765992.SGD","LU2023250504.SGD","LU2362540622.SGD","LU0058720904.USD","LU0889565916.HKD","LU2089984988.USD","REGN","LU0109394709.USD","LU2468319806.SGD","LU2106854487.HKD","CHMP","BK4585","LU0114720955.EUR","LU0289739699.SGD","BK4139","LU2362541273.HKD","LU2237438978.USD","LU1974910355.USD","LU2362541513.USD"],"gpt_icon":0},{"id":"2514340323","title":"Linvoseltamab Recommended for EU Approval by the Chmp to Treat Relapsed/Refractory Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2514340323","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514340323?lang=en_us&edition=fundamental","pubTime":"2025-02-28 20:00","pubTimestamp":1740744002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nTUA9DHM4J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2023250504.SGD","BK4588","LU0053666078.USD","LU2106854487.HKD","LU0889565916.HKD","LU1974910355.USD","LU2089984988.USD","LU0058720904.USD","LU2362540622.SGD","LU2362541273.HKD","LU2362541513.USD","BK4585","REGN","LU0320765992.SGD","LU0289739699.SGD","LU2237438978.USD","LU0823416689.USD","BK4139","LU0114720955.EUR","LU1917777945.USD","LU0882574055.USD","LU0109394709.USD","LU2468319806.SGD"],"gpt_icon":0},{"id":"2514323305","title":"Regeneron Pharmaceuticals Inc - European Commission Final Decision Expected in Coming Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2514323305","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514323305?lang=en_us&edition=fundamental","pubTime":"2025-02-28 20:00","pubTimestamp":1740744002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nTUA9DHM4J:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0114720955.EUR","LU0053666078.USD","LU2023250504.SGD","BK4588","LU2362540622.SGD","LU0882574055.USD","LU0320765992.SGD","BK4585","LU1974910355.USD","LU0289739699.SGD","LU2362541513.USD","LU0058720904.USD","LU2237438978.USD","REGN","LU2468319806.SGD","BK4139","LU0109394709.USD","LU0889565916.HKD","LU1917777945.USD","LU2362541273.HKD","LU2089984988.USD","LU2106854487.HKD","LU0823416689.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/REGN\",params:#limit:5,,,undefined,":[{"date":"2025-04-29","symbol":"REGN","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":6.88,"defaultRemindTime":1745913600000,"name":null,"time":"Pre-Market","dateTimestamp":1745899200000,"actualEps":null},{"date":"2025-02-20","symbol":"REGN","amount":0.88,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-20","defaultRemindTime":1740061800000,"name":"再生元制药公司","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-20","payableDate":"2025-02-20","currency":"USD","dateTimestamp":1740027600000,"payDate":"2025-03-20"},{"market":"US","date":"2025-02-04","symbol":"REGN","fiscalQuarterEnding":"2024/12","expectedEps":9.62,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738645200000,"reportTimeType":"pre","actualEps":9.9},{"market":"US","date":"2024-10-31","symbol":"REGN","fiscalQuarterEnding":"2024/09","expectedEps":10.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"pre","actualEps":11.73},{"market":"US","date":"2024-08-01","symbol":"REGN","fiscalQuarterEnding":"2024/06","expectedEps":8.93,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"pre","actualEps":10.1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"REGN\",market:\"US\",,,undefined,":[{"executeDate":"2025-02-20","recordDate":"2025-02-20","paymentDate":"2025-03-20","value":0.88,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"REGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.4286,"hold":0.25,"sell":0.0357,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4286,"analysts":28,"updateTime":1741924800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/REGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"REGN","date":"2025-04-04","current":14.810668,"percent":0.371545,"low":7.447139,"twenty":11.205526,"median":17.220578,"eighty":24.757629,"high":30.763504,"avg":17.728877,"sd":6.29617,"marketCap":65353551816},"quantilePoints":[{"date":"2020-04-09","current":26.391819,"twenty":19.870525,"median":60.470164,"eighty":116.641136,"marketCap":55839811478},{"date":"2020-04-17","current":29.264276,"twenty":19.849021,"median":60.490119,"eighty":116.648995,"marketCap":61917354902},{"date":"2020-04-24","current":29.801222,"twenty":19.849021,"median":60.209042,"eighty":116.648995,"marketCap":63053425873},{"date":"2020-05-01","current":27.658541,"twenty":19.849021,"median":58.652905,"eighty":116.648995,"marketCap":58519940122},{"date":"2020-05-08","current":27.526215,"twenty":19.849021,"median":57.393234,"eighty":116.585674,"marketCap":62740502883},{"date":"2020-05-15","current":28.176995,"twenty":19.849021,"median":53.421195,"eighty":115.221021,"marketCap":64223824676},{"date":"2020-05-22","current":27.844277,"twenty":19.849021,"median":51.799637,"eighty":114.184286,"marketCap":63465459705},{"date":"2020-05-29","current":27.303609,"twenty":19.849021,"median":51.530268,"eighty":113.633942,"marketCap":62233116768},{"date":"2020-06-05","current":26.599198,"twenty":19.849021,"median":51.349129,"eighty":112.594309,"marketCap":60627552930},{"date":"2020-06-12","current":26.215582,"twenty":19.849021,"median":51.102486,"eighty":112.289501,"marketCap":59753175659},{"date":"2020-06-19","current":28.689708,"twenty":19.849021,"median":50.420041,"eighty":111.71033,"marketCap":65392452064},{"date":"2020-06-26","current":27.239005,"twenty":19.849021,"median":49.850558,"eighty":110.92935,"marketCap":62085863918},{"date":"2020-07-02","current":27.733117,"twenty":19.849021,"median":40.392331,"eighty":110.784746,"marketCap":63212094340},{"date":"2020-07-10","current":27.662275,"twenty":19.849021,"median":31.979399,"eighty":110.206964,"marketCap":63050623973},{"date":"2020-07-17","current":28.695946,"twenty":19.849021,"median":31.36985,"eighty":108.726161,"marketCap":65406669581},{"date":"2020-07-24","current":27.131182,"twenty":19.849021,"median":31.004812,"eighty":106.696094,"marketCap":61840103988},{"date":"2020-07-31","current":28.161734,"twenty":19.849021,"median":30.808341,"eighty":104.408478,"marketCap":64189040838},{"date":"2020-08-07","current":21.875339,"twenty":19.849021,"median":30.656632,"eighty":101.923911,"marketCap":65265075387},{"date":"2020-08-14","current":21.60587,"twenty":19.849021,"median":30.354205,"eighty":101.37008,"marketCap":64461113542},{"date":"2020-08-21","current":21.356152,"twenty":19.849021,"median":30.042238,"eighty":99.974583,"marketCap":63716080837},{"date":"2020-08-28","current":21.254572,"twenty":19.849021,"median":29.867177,"eighty":98.620251,"marketCap":63413016686},{"date":"2020-09-04","current":20.469796,"twenty":19.849021,"median":29.681793,"eighty":97.739726,"marketCap":61071635658},{"date":"2020-09-11","current":19.2138,"twenty":19.673575,"median":29.474412,"eighty":97.336675,"marketCap":57324373708},{"date":"2020-09-18","current":19.583792,"twenty":19.656234,"median":29.203553,"eighty":96.645594,"marketCap":58428242785},{"date":"2020-09-25","current":20.247589,"twenty":19.637789,"median":29.093505,"eighty":95.995591,"marketCap":60408682828},{"date":"2020-10-02","current":19.920981,"twenty":19.637789,"median":28.953278,"eighty":94.856997,"marketCap":59434247398},{"date":"2020-10-09","current":21.235526,"twenty":19.637789,"median":28.860353,"eighty":93.407176,"marketCap":63356192158},{"date":"2020-10-16","current":21.153345,"twenty":19.637789,"median":28.756642,"eighty":89.782622,"marketCap":63111004841},{"date":"2020-10-23","current":20.450397,"twenty":19.637789,"median":28.691316,"eighty":88.348748,"marketCap":61013758824},{"date":"2020-10-30","current":19.171828,"twenty":19.596771,"median":28.536662,"eighty":84.18776,"marketCap":57199149284},{"date":"2020-11-06","current":19.330759,"twenty":19.563112,"median":28.419067,"eighty":80.669454,"marketCap":61007874618},{"date":"2020-11-13","current":18.942826,"twenty":19.391778,"median":28.342989,"eighty":76.671574,"marketCap":59783558673},{"date":"2020-11-20","current":17.347954,"twenty":19.273386,"median":28.194062,"eighty":74.98798,"marketCap":54750142517},{"date":"2020-11-27","current":17.191109,"twenty":19.172764,"median":28.166858,"eighty":74.433116,"marketCap":54255138915},{"date":"2020-12-04","current":16.468751,"twenty":19.105699,"median":28.124531,"eighty":73.576979,"marketCap":51975378191},{"date":"2020-12-11","current":16.0447,"twenty":19.031974,"median":28.045787,"eighty":73.249222,"marketCap":50637074210},{"date":"2020-12-18","current":16.684121,"twenty":18.978847,"median":28.003825,"eighty":72.725467,"marketCap":52655084629},{"date":"2020-12-24","current":16.351033,"twenty":18.951722,"median":27.893932,"eighty":72.508831,"marketCap":51603861628},{"date":"2020-12-31","current":16.156398,"twenty":18.869944,"median":27.783005,"eighty":72.122981,"marketCap":50989592766},{"date":"2021-01-08","current":16.67877,"twenty":18.812345,"median":27.748475,"eighty":71.867927,"marketCap":52638197512},{"date":"2021-01-15","current":17.320865,"twenty":18.741004,"median":27.670408,"eighty":71.690256,"marketCap":54664651490},{"date":"2021-01-22","current":17.984699,"twenty":18.702345,"median":27.64431,"eighty":71.398793,"marketCap":56759709378},{"date":"2021-01-29","current":16.849661,"twenty":18.613885,"median":27.588588,"eighty":71.196483,"marketCap":53177529795},{"date":"2021-02-05","current":14.990488,"twenty":18.469712,"median":27.52903,"eighty":70.956334,"marketCap":52664583632},{"date":"2021-02-12","current":14.395598,"twenty":18.339492,"median":27.404838,"eighty":70.822506,"marketCap":50574613240},{"date":"2021-02-19","current":13.94353,"twenty":18.247865,"median":27.322464,"eighty":70.650351,"marketCap":48986410835},{"date":"2021-02-26","current":13.356584,"twenty":18.183087,"median":27.239458,"eighty":70.34583,"marketCap":46924351319},{"date":"2021-03-05","current":13.682665,"twenty":18.137069,"median":27.131182,"eighty":70.094632,"marketCap":48069939939},{"date":"2021-03-12","current":13.975842,"twenty":18.094122,"median":27.034693,"eighty":69.991059,"marketCap":49099928253},{"date":"2021-03-19","current":14.042244,"twenty":17.992123,"median":26.957419,"eighty":69.774786,"marketCap":49333211754},{"date":"2021-03-26","current":14.1374,"twenty":17.91755,"median":26.838925,"eighty":69.560413,"marketCap":49667515342},{"date":"2021-04-01","current":14.078706,"twenty":17.836459,"median":26.740955,"eighty":69.380807,"marketCap":49461309390},{"date":"2021-04-09","current":14.08582,"twenty":17.582883,"median":26.667813,"eighty":69.047731,"marketCap":49486304051},{"date":"2021-04-16","current":14.898948,"twenty":17.531653,"median":26.603923,"eighty":68.92796,"marketCap":52342985492},{"date":"2021-04-23","current":14.400461,"twenty":17.378502,"median":26.576788,"eighty":68.754213,"marketCap":50591699595},{"date":"2021-04-30","current":14.184148,"twenty":17.314319,"median":26.47571,"eighty":68.667059,"marketCap":49831747330},{"date":"2021-05-07","current":12.848195,"twenty":17.236982,"median":26.416524,"eighty":68.548435,"marketCap":51441604940},{"date":"2021-05-14","current":13.362123,"twenty":17.131868,"median":26.350888,"eighty":68.476599,"marketCap":53499269138},{"date":"2021-05-21","current":13.106065,"twenty":16.947039,"median":26.270161,"eighty":68.395732,"marketCap":52474061510},{"date":"2021-05-28","current":12.995106,"twenty":16.837354,"median":26.029338,"eighty":68.15674,"marketCap":52029804872},{"date":"2021-06-04","current":13.239784,"twenty":16.702149,"median":25.825146,"eighty":68.017841,"marketCap":53009447716},{"date":"2021-06-11","current":13.593093,"twenty":16.634935,"median":25.762014,"eighty":67.890019,"marketCap":54424027129},{"date":"2021-06-18","current":13.913037,"twenty":16.514074,"median":25.58899,"eighty":67.722101,"marketCap":55705018881},{"date":"2021-06-25","current":14.239706,"twenty":16.438175,"median":25.425582,"eighty":67.525077,"marketCap":57012935279},{"date":"2021-07-02","current":15.095563,"twenty":16.378422,"median":25.38134,"eighty":67.387984,"marketCap":60439614106},{"date":"2021-07-09","current":15.011762,"twenty":16.299089,"median":25.245133,"eighty":67.28571,"marketCap":60104091610},{"date":"2021-07-16","current":15.085217,"twenty":16.168829,"median":25.161304,"eighty":66.948314,"marketCap":60398191576},{"date":"2021-07-23","current":15.165656,"twenty":16.140773,"median":25.057563,"eighty":66.699512,"marketCap":60720251750},{"date":"2021-07-30","current":14.862006,"twenty":16.05773,"median":24.844212,"eighty":66.473671,"marketCap":59504500482},{"date":"2021-08-06","current":10.234607,"twenty":15.941934,"median":24.580228,"eighty":66.222266,"marketCap":63509831394},{"date":"2021-08-13","current":10.467996,"twenty":15.811105,"median":24.409963,"eighty":65.572203,"marketCap":64958104241},{"date":"2021-08-20","current":11.112707,"twenty":15.71172,"median":24.133895,"eighty":65.35903,"marketCap":68958789033},{"date":"2021-08-27","current":11.113042,"twenty":15.594292,"median":23.952572,"eighty":64.943681,"marketCap":68960868391},{"date":"2021-09-03","current":11.385804,"twenty":15.416611,"median":23.896291,"eighty":64.163045,"marketCap":70653465803},{"date":"2021-09-10","current":10.898585,"twenty":15.358543,"median":23.822687,"eighty":64.001642,"marketCap":67630079271},{"date":"2021-09-17","current":10.921874,"twenty":15.31188,"median":23.556993,"eighty":63.614678,"marketCap":67774594652},{"date":"2021-09-24","current":10.704401,"twenty":15.216063,"median":23.36376,"eighty":63.039237,"marketCap":66425091310},{"date":"2021-10-01","current":9.563257,"twenty":15.168295,"median":23.248274,"eighty":62.60394,"marketCap":59343837641},{"date":"2021-10-08","current":9.215268,"twenty":15.152615,"median":23.044477,"eighty":62.187301,"marketCap":57184424358},{"date":"2021-10-15","current":9.269217,"twenty":15.096804,"median":22.886718,"eighty":61.909902,"marketCap":57519200996},{"date":"2021-10-22","current":9.589562,"twenty":15.075632,"median":22.781044,"eighty":60.689685,"marketCap":59507067244},{"date":"2021-10-29","current":10.721826,"twenty":15.02843,"median":22.711601,"eighty":58.441572,"marketCap":66533217926},{"date":"2021-11-05","current":9.140146,"twenty":15.010362,"median":22.587367,"eighty":56.983625,"marketCap":63939894320},{"date":"2021-11-12","current":9.433987,"twenty":14.972274,"median":22.403299,"eighty":52.676989,"marketCap":65995456216},{"date":"2021-11-19","current":9.75503,"twenty":14.914028,"median":22.242861,"eighty":51.731325,"marketCap":68241309194},{"date":"2021-11-26","current":9.615582,"twenty":14.873644,"median":22.206358,"eighty":51.46717,"marketCap":67265806015},{"date":"2021-12-03","current":9.493174,"twenty":14.846146,"median":22.027357,"eighty":51.289641,"marketCap":66409496151},{"date":"2021-12-10","current":10.006722,"twenty":14.763396,"median":21.89368,"eighty":50.996878,"marketCap":70002024471},{"date":"2021-12-17","current":9.255829,"twenty":14.645835,"median":21.852902,"eighty":50.192382,"marketCap":64749154191},{"date":"2021-12-23","current":9.347001,"twenty":14.543935,"median":21.806579,"eighty":49.835452,"marketCap":65386942979},{"date":"2021-12-31","current":9.43877,"twenty":14.480705,"median":21.69052,"eighty":32.798336,"marketCap":66028913989},{"date":"2022-01-07","current":9.023417,"twenty":14.400343,"median":21.58144,"eighty":31.955254,"marketCap":63123315560},{"date":"2022-01-14","current":9.195447,"twenty":14.360499,"median":21.468059,"eighty":31.332217,"marketCap":64326749814},{"date":"2022-01-21","current":9.287515,"twenty":14.29746,"median":21.412668,"eighty":31.053495,"marketCap":64970811934},{"date":"2022-01-28","current":9.340125,"twenty":14.271924,"median":21.249665,"eighty":30.821672,"marketCap":65338847431},{"date":"2022-02-04","current":8.06582,"twenty":14.211698,"median":21.155814,"eighty":30.665092,"marketCap":65133918575},{"date":"2022-02-11","current":8.414784,"twenty":14.141195,"median":20.886786,"eighty":30.397746,"marketCap":67951902021},{"date":"2022-02-18","current":8.107934,"twenty":14.100469,"median":20.718789,"eighty":30.063963,"marketCap":65473995536},{"date":"2022-02-25","current":8.154462,"twenty":14.0749,"median":20.630748,"eighty":29.944922,"marketCap":65849726202},{"date":"2022-03-04","current":8.177528,"twenty":14.052898,"median":20.548589,"eighty":29.711783,"marketCap":66035994945},{"date":"2022-03-11","current":8.469748,"twenty":13.990355,"median":20.497058,"eighty":29.510771,"marketCap":68395753827},{"date":"2022-03-18","current":9.041269,"twenty":13.952186,"median":20.431603,"eighty":29.231348,"marketCap":73010961095},{"date":"2022-03-25","current":8.96337,"twenty":13.923409,"median":20.297711,"eighty":29.102336,"marketCap":72381904938},{"date":"2022-04-01","current":9.158447,"twenty":13.87369,"median":20.180575,"eighty":28.966736,"marketCap":73957206312},{"date":"2022-04-08","current":9.738536,"twenty":13.848877,"median":20.056598,"eighty":28.871934,"marketCap":78641599112},{"date":"2022-04-14","current":9.661823,"twenty":13.817339,"median":19.925312,"eighty":28.815517,"marketCap":78022122491},{"date":"2022-04-22","current":9.180836,"twenty":13.785109,"median":19.790673,"eighty":28.696957,"marketCap":74138001167},{"date":"2022-04-29","current":8.794298,"twenty":13.737566,"median":19.660289,"eighty":28.556678,"marketCap":71016593927},{"date":"2022-05-06","current":8.46164,"twenty":13.72215,"median":19.591904,"eighty":28.472288,"marketCap":67131266171},{"date":"2022-05-13","current":8.766805,"twenty":13.695689,"median":19.451906,"eighty":28.362701,"marketCap":69552323150},{"date":"2022-05-20","current":8.97894,"twenty":13.651777,"median":19.315239,"eighty":28.201625,"marketCap":71235318701},{"date":"2022-05-27","current":9.408914,"twenty":13.61647,"median":19.182482,"eighty":28.169777,"marketCap":74646563203},{"date":"2022-06-03","current":8.560781,"twenty":13.580763,"median":19.147609,"eighty":28.138912,"marketCap":67917813387},{"date":"2022-06-10","current":7.76575,"twenty":13.496152,"median":19.040029,"eighty":28.05351,"marketCap":61610351191},{"date":"2022-06-17","current":7.88988,"twenty":13.458929,"median":18.983291,"eighty":28.012848,"marketCap":62595151404},{"date":"2022-06-24","current":8.318225,"twenty":13.394252,"median":18.968689,"eighty":27.917096,"marketCap":65993466363},{"date":"2022-07-01","current":8.086125,"twenty":13.329334,"median":18.871653,"eighty":27.782289,"marketCap":64152083907},{"date":"2022-07-08","current":8.44154,"twenty":13.241565,"median":18.818752,"eighty":27.753004,"marketCap":66971801804},{"date":"2022-07-15","current":8.250999,"twenty":13.112583,"median":18.780003,"eighty":27.691117,"marketCap":65460122702},{"date":"2022-07-22","current":7.959958,"twenty":13.007521,"median":18.702505,"eighty":27.643858,"marketCap":63151121765},{"date":"2022-07-29","current":7.89993,"twenty":12.891389,"median":18.620106,"eighty":27.587706,"marketCap":62674883587},{"date":"2022-08-05","current":11.535488,"twenty":11.550716,"median":18.471047,"eighty":27.528467,"marketCap":65600015462},{"date":"2022-08-12","current":11.819359,"twenty":11.550716,"median":18.341073,"eighty":27.404209,"marketCap":67214331124},{"date":"2022-08-19","current":11.624785,"twenty":11.550716,"median":18.231129,"eighty":27.303428,"marketCap":66107829991},{"date":"2022-08-26","current":11.207815,"twenty":11.371909,"median":18.181433,"eighty":27.225906,"marketCap":63736603409},{"date":"2022-09-02","current":10.915297,"twenty":11.30967,"median":18.134856,"eighty":27.121826,"marketCap":62073109919},{"date":"2022-09-09","current":13.616768,"twenty":11.259308,"median":18.095368,"eighty":27.037827,"marketCap":77435835791},{"date":"2022-09-16","current":13.353201,"twenty":11.259308,"median":17.997073,"eighty":26.966349,"marketCap":75936981116},{"date":"2022-09-23","current":13.109373,"twenty":11.259308,"median":17.919992,"eighty":26.835951,"marketCap":74550380180},{"date":"2022-09-30","current":12.95033,"twenty":11.259308,"median":17.763862,"eighty":26.722775,"marketCap":73645935776},{"date":"2022-10-07","current":13.580109,"twenty":11.259308,"median":17.582147,"eighty":26.649626,"marketCap":77227364563},{"date":"2022-10-14","current":13.837473,"twenty":11.259308,"median":17.514489,"eighty":26.601993,"marketCap":78690939491},{"date":"2022-10-21","current":13.421066,"twenty":11.259308,"median":17.357987,"eighty":26.567778,"marketCap":76322920159},{"date":"2022-10-28","current":14.113824,"twenty":11.259308,"median":17.305502,"eighty":26.472046,"marketCap":80262491824},{"date":"2022-11-04","current":14.720939,"twenty":11.259308,"median":17.230044,"eighty":26.401701,"marketCap":79055860306},{"date":"2022-11-11","current":14.606387,"twenty":11.259308,"median":17.119207,"eighty":26.346411,"marketCap":78440681160},{"date":"2022-11-18","current":14.651731,"twenty":11.259308,"median":16.930926,"eighty":26.239227,"marketCap":78684189572},{"date":"2022-11-25","current":14.641787,"twenty":11.259308,"median":16.849661,"eighty":26.033735,"marketCap":78630788605},{"date":"2022-12-02","current":15.241595,"twenty":11.259308,"median":16.684121,"eighty":25.823128,"marketCap":81851934964},{"date":"2022-12-09","current":14.916831,"twenty":11.259308,"median":16.625596,"eighty":25.738839,"marketCap":80107859366},{"date":"2022-12-16","current":14.382056,"twenty":11.259308,"median":16.468751,"eighty":25.567197,"marketCap":77235955333},{"date":"2022-12-23","current":14.453054,"twenty":11.259308,"median":16.426279,"eighty":25.414911,"marketCap":77617238241},{"date":"2022-12-30","current":14.348645,"twenty":11.259308,"median":16.386349,"eighty":25.384384,"marketCap":77056528083},{"date":"2023-01-06","current":14.660083,"twenty":11.259308,"median":16.317075,"eighty":25.250581,"marketCap":78729046385},{"date":"2023-01-13","current":14.361373,"twenty":11.259308,"median":16.169536,"eighty":25.174538,"marketCap":77124881321},{"date":"2023-01-20","current":14.358788,"twenty":11.259308,"median":16.151382,"eighty":25.098264,"marketCap":77110997070},{"date":"2023-01-27","current":14.773045,"twenty":11.259308,"median":16.092523,"eighty":24.875579,"marketCap":79335681376},{"date":"2023-02-03","current":19.278951,"twenty":11.259308,"median":15.99554,"eighty":24.688912,"marketCap":83639799356},{"date":"2023-02-10","current":18.637362,"twenty":11.259308,"median":15.99554,"eighty":24.479131,"marketCap":80856330298},{"date":"2023-02-17","current":18.419158,"twenty":11.259308,"median":15.99554,"eighty":24.334872,"marketCap":79909674829},{"date":"2023-02-24","current":18.62211,"twenty":11.259308,"median":15.99554,"eighty":24.08253,"marketCap":80790160468},{"date":"2023-03-03","current":19.17094,"twenty":11.259308,"median":15.99554,"eighty":23.912342,"marketCap":83171207087},{"date":"2023-03-10","current":18.376354,"twenty":11.259308,"median":15.99554,"eighty":23.83133,"marketCap":79723972404},{"date":"2023-03-17","current":18.392344,"twenty":11.259308,"median":15.99554,"eighty":23.634714,"marketCap":79793343999},{"date":"2023-03-24","current":20.172169,"twenty":11.259308,"median":15.99554,"eighty":23.395584,"marketCap":87514936240},{"date":"2023-03-31","current":20.213251,"twenty":11.270868,"median":16.006911,"eighty":23.269698,"marketCap":87693167878},{"date":"2023-04-06","current":20.300582,"twenty":11.270868,"median":16.006911,"eighty":23.16464,"marketCap":88072043517},{"date":"2023-04-14","current":20.426781,"twenty":11.259308,"median":15.99554,"eighty":22.981137,"marketCap":88619545496},{"date":"2023-04-21","current":19.633424,"twenty":11.259308,"median":15.99554,"eighty":22.826311,"marketCap":85177647089},{"date":"2023-04-28","current":19.560756,"twenty":11.259308,"median":15.99554,"eighty":22.744778,"marketCap":84862383141},{"date":"2023-05-05","current":19.3053,"twenty":11.259308,"median":15.99554,"eighty":22.693077,"marketCap":80748278285},{"date":"2023-05-12","current":19.092498,"twenty":11.247747,"median":15.988674,"eighty":22.679792,"marketCap":79858192074},{"date":"2023-05-19","current":19.141409,"twenty":11.247747,"median":15.988674,"eighty":22.52179,"marketCap":80062772659},{"date":"2023-05-26","current":18.565743,"twenty":11.247747,"median":15.988674,"eighty":22.52179,"marketCap":77654934150},{"date":"2023-06-02","current":18.723744,"twenty":11.247747,"median":15.988674,"eighty":22.416292,"marketCap":78315804417},{"date":"2023-06-09","current":19.209014,"twenty":11.247747,"median":15.988674,"eighty":22.202364,"marketCap":80345543730},{"date":"2023-06-16","current":20.052795,"twenty":11.247747,"median":15.988674,"eighty":21.930123,"marketCap":83874826599},{"date":"2023-06-23","current":19.969313,"twenty":11.236187,"median":15.981807,"eighty":21.872257,"marketCap":83525647171},{"date":"2023-06-30","current":18.141164,"twenty":11.224626,"median":15.96462,"eighty":21.812599,"marketCap":75879046138},{"date":"2023-07-07","current":18.049231,"twenty":11.224626,"median":15.96462,"eighty":21.69052,"marketCap":75494520326},{"date":"2023-07-14","current":18.462799,"twenty":11.224626,"median":15.96462,"eighty":21.546615,"marketCap":77224350928},{"date":"2023-07-21","current":18.51504,"twenty":11.224626,"median":15.96462,"eighty":21.443977,"marketCap":77442855847},{"date":"2023-07-28","current":19.069195,"twenty":11.224626,"median":15.96462,"eighty":21.26942,"marketCap":79760721743},{"date":"2023-08-04","current":19.014155,"twenty":11.224626,"median":15.96462,"eighty":21.191438,"marketCap":81741853001},{"date":"2023-08-11","current":19.545551,"twenty":11.224626,"median":15.96462,"eighty":20.904333,"marketCap":84026322961},{"date":"2023-08-18","current":19.637239,"twenty":11.224626,"median":15.96462,"eighty":20.742089,"marketCap":84420489392},{"date":"2023-08-25","current":20.487077,"twenty":11.224626,"median":15.96462,"eighty":20.708932,"marketCap":88073945988},{"date":"2023-09-01","current":20.370742,"twenty":11.224626,"median":15.96462,"eighty":20.579258,"marketCap":87573820839},{"date":"2023-09-08","current":20.340426,"twenty":11.224626,"median":15.96462,"eighty":20.556869,"marketCap":87443491616},{"date":"2023-09-15","current":20.515915,"twenty":11.224626,"median":15.96462,"eighty":20.525527,"marketCap":88197917688},{"date":"2023-09-22","current":20.294089,"twenty":11.224626,"median":15.96462,"eighty":20.503675,"marketCap":87244289226},{"date":"2023-09-29","current":20.569892,"twenty":11.224626,"median":15.96462,"eighty":20.497429,"marketCap":88429967281},{"date":"2023-10-06","current":20.484859,"twenty":11.224626,"median":15.96462,"eighty":20.47919,"marketCap":88064409704},{"date":"2023-10-13","current":20.66651,"twenty":11.224626,"median":15.96462,"eighty":20.47919,"marketCap":88845325455},{"date":"2023-10-20","current":19.930788,"twenty":11.224626,"median":15.96462,"eighty":20.469796,"marketCap":85682457723},{"date":"2023-10-27","current":19.520904,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":83920364243},{"date":"2023-11-03","current":21.737851,"twenty":11.217472,"median":15.933685,"eighty":20.408361,"marketCap":86757938711},{"date":"2023-11-10","current":21.323755,"twenty":11.217472,"median":15.933685,"eighty":20.408361,"marketCap":85105237415},{"date":"2023-11-17","current":21.224631,"twenty":11.217472,"median":15.933685,"eighty":20.421192,"marketCap":84709626635},{"date":"2023-11-24","current":21.271528,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":84896797327},{"date":"2023-12-01","current":21.951269,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":87609708889},{"date":"2023-12-08","current":22.627279,"twenty":11.219857,"median":15.940559,"eighty":20.455788,"marketCap":90307731873},{"date":"2023-12-15","current":23.341925,"twenty":11.219857,"median":15.940559,"eighty":20.455788,"marketCap":93159957984},{"date":"2023-12-22","current":22.432763,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":89531398889},{"date":"2023-12-29","current":23.493808,"twenty":11.215088,"median":15.919407,"eighty":20.445674,"marketCap":93766135792},{"date":"2024-01-05","current":24.305712,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":97006528395},{"date":"2024-01-12","current":24.406967,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":97410646934},{"date":"2024-01-19","current":24.780811,"twenty":11.212541,"median":15.891644,"eighty":20.415603,"marketCap":98902695120},{"date":"2024-01-26","current":25.283622,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":100909462708},{"date":"2024-02-02","current":25.521038,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":101857014335},{"date":"2024-02-09","current":25.724697,"twenty":11.212703,"median":15.905129,"eighty":20.459114,"marketCap":101705162231},{"date":"2024-02-16","current":25.950297,"twenty":11.212703,"median":15.905129,"eighty":20.47919,"marketCap":102597095968},{"date":"2024-02-23","current":26.226454,"twenty":11.212703,"median":15.905129,"eighty":20.497429,"marketCap":103688908831},{"date":"2024-03-01","current":26.259071,"twenty":11.215088,"median":15.919407,"eighty":20.518368,"marketCap":103817863106},{"date":"2024-03-08","current":26.455316,"twenty":11.215088,"median":15.919407,"eighty":20.545637,"marketCap":104593737995},{"date":"2024-03-15","current":26.067447,"twenty":11.215088,"median":15.919407,"eighty":20.571273,"marketCap":103060256739},{"date":"2024-03-22","current":26.311258,"twenty":11.215088,"median":15.919407,"eighty":20.621194,"marketCap":104024189946},{"date":"2024-03-28","current":26.264779,"twenty":11.215088,"median":15.919407,"eighty":20.655603,"marketCap":103840430104},{"date":"2024-04-05","current":25.468926,"twenty":11.212703,"median":15.905129,"eighty":20.723691,"marketCap":100693945789},{"date":"2024-04-12","current":25.015007,"twenty":11.212703,"median":15.905129,"eighty":20.904157,"marketCap":98899332126},{"date":"2024-04-19","current":24.299337,"twenty":11.212703,"median":15.947434,"eighty":21.122307,"marketCap":96069860405},{"date":"2024-04-26","current":24.304801,"twenty":11.215088,"median":16.055559,"eighty":21.212036,"marketCap":96091459812},{"date":"2024-05-03","current":26.22078,"twenty":11.215088,"median":16.138956,"eighty":21.263447,"marketCap":101154526467},{"date":"2024-05-10","current":27.070653,"twenty":11.215088,"median":16.168653,"eighty":21.31672,"marketCap":104433166904},{"date":"2024-05-17","current":27.070094,"twenty":11.215088,"median":16.294592,"eighty":21.377367,"marketCap":104431009193},{"date":"2024-05-24","current":27.42218,"twenty":11.215088,"median":16.403186,"eighty":21.543145,"marketCap":105789287676},{"date":"2024-05-31","current":27.124068,"twenty":11.215088,"median":16.446392,"eighty":21.604318,"marketCap":104639228214},{"date":"2024-06-07","current":27.987644,"twenty":11.215088,"median":16.556015,"eighty":21.765364,"marketCap":107970732547},{"date":"2024-06-14","current":28.708036,"twenty":11.212703,"median":16.641161,"eighty":21.875339,"marketCap":110749863104},{"date":"2024-06-21","current":29.206942,"twenty":11.212541,"median":16.702347,"eighty":21.926914,"marketCap":112674540478},{"date":"2024-06-28","current":29.387879,"twenty":11.212055,"median":16.849661,"eighty":22.012139,"marketCap":113372559682},{"date":"2024-07-05","current":28.639241,"twenty":11.212055,"median":16.930926,"eighty":22.201171,"marketCap":110484464767},{"date":"2024-07-12","current":30.210346,"twenty":11.212055,"median":17.140309,"eighty":22.42349,"marketCap":116545472325},{"date":"2024-07-15","current":30.763504,"twenty":11.212055,"median":17.191109,"eighty":22.533173,"marketCap":118679447575},{"date":"2024-08-02","current":27.30119,"twenty":11.206899,"median":17.301169,"eighty":22.615128,"marketCap":117987551031},{"date":"2024-08-09","current":27.805935,"twenty":11.206899,"median":17.352971,"eighty":22.804619,"marketCap":120168907862},{"date":"2024-08-16","current":29.353886,"twenty":11.206899,"median":17.547174,"eighty":23.185349,"marketCap":126858689969},{"date":"2024-08-23","current":29.661828,"twenty":11.206899,"median":17.668241,"eighty":23.520288,"marketCap":128189522712},{"date":"2024-08-30","current":29.443796,"twenty":11.206899,"median":17.89624,"eighty":23.992786,"marketCap":127247254273},{"date":"2024-09-06","current":28.735255,"twenty":11.206899,"median":18.004331,"eighty":24.127024,"marketCap":124185151686},{"date":"2024-09-13","current":29.082408,"twenty":11.206899,"median":18.146003,"eighty":24.305165,"marketCap":125685441639},{"date":"2024-09-20","current":28.726014,"twenty":11.206899,"median":18.30367,"eighty":24.388542,"marketCap":124145215910},{"date":"2024-09-27","current":25.973018,"twenty":11.206899,"median":18.360535,"eighty":24.456418,"marketCap":112247592778},{"date":"2024-10-04","current":25.339402,"twenty":11.206899,"median":18.388792,"eighty":24.700046,"marketCap":109509293778},{"date":"2024-10-11","current":24.950541,"twenty":11.206899,"median":18.407637,"eighty":24.906035,"marketCap":107828753161},{"date":"2024-10-18","current":24.930811,"twenty":11.206899,"median":18.470866,"eighty":25.028446,"marketCap":107743484883},{"date":"2024-10-25","current":23.199293,"twenty":11.206899,"median":18.52949,"eighty":25.028446,"marketCap":100260383988},{"date":"2024-10-31","current":23.046696,"twenty":11.206899,"median":18.566384,"eighty":25.028446,"marketCap":99600904015},{"date":"2024-11-08","current":19.05799,"twenty":11.206442,"median":18.637362,"eighty":25.035165,"marketCap":88705416518},{"date":"2024-11-15","current":18.087847,"twenty":11.206442,"median":18.657932,"eighty":25.035165,"marketCap":84189883902},{"date":"2024-11-22","current":17.20924,"twenty":11.206442,"median":18.657932,"eighty":25.035165,"marketCap":80100405829},{"date":"2024-11-29","current":17.341458,"twenty":11.206442,"median":18.64179,"eighty":25.035165,"marketCap":80715817946},{"date":"2024-12-06","current":17.750134,"twenty":11.206442,"median":18.605435,"eighty":25.035165,"marketCap":82618000854},{"date":"2024-12-13","current":17.127643,"twenty":11.206442,"median":18.54394,"eighty":25.035165,"marketCap":79720614785},{"date":"2024-12-20","current":16.371315,"twenty":11.206442,"median":18.478932,"eighty":25.035165,"marketCap":76200285330},{"date":"2024-12-27","current":16.566176,"twenty":11.206442,"median":18.419158,"eighty":25.035165,"marketCap":77107265077},{"date":"2025-01-03","current":16.531734,"twenty":11.206442,"median":18.397243,"eighty":25.035165,"marketCap":76946956675},{"date":"2025-01-10","current":16.957053,"twenty":11.205984,"median":18.379244,"eighty":25.041885,"marketCap":78926604046},{"date":"2025-01-17","current":16.024125,"twenty":11.205984,"median":18.326784,"eighty":25.041885,"marketCap":74584290575},{"date":"2025-01-24","current":16.056718,"twenty":11.205984,"median":18.268644,"eighty":25.041885,"marketCap":74735991813},{"date":"2025-01-31","current":15.789506,"twenty":11.205984,"median":18.268644,"eighty":25.041885,"marketCap":73492256835},{"date":"2025-02-07","current":17.513328,"twenty":11.205984,"median":18.205402,"eighty":25.041885,"marketCap":77279312131},{"date":"2025-02-14","current":16.353971,"twenty":11.205984,"median":18.068539,"eighty":25.041885,"marketCap":72163532332},{"date":"2025-02-21","current":16.881503,"twenty":11.205984,"median":17.989927,"eighty":25.041885,"marketCap":74491319165},{"date":"2025-02-28","current":17.045462,"twenty":11.205984,"median":17.861315,"eighty":25.041885,"marketCap":75214806015},{"date":"2025-03-07","current":16.940198,"twenty":11.205526,"median":17.547284,"eighty":24.953276,"marketCap":74750318896},{"date":"2025-03-14","current":16.507743,"twenty":11.205526,"median":17.434844,"eighty":24.953276,"marketCap":72842068816},{"date":"2025-03-21","current":16.071408,"twenty":11.205526,"median":17.347954,"eighty":24.876365,"marketCap":70916694786},{"date":"2025-03-28","current":15.421634,"twenty":11.205526,"median":17.320865,"eighty":24.876365,"marketCap":68049503556},{"date":"2025-04-04","current":14.810668,"twenty":11.205526,"median":17.220578,"eighty":24.757629,"marketCap":65353551816}],"updateTime":1743973626085}}}